pharma · Covid-19 · Chronic Myocardial Ischemia · LSTA
Lisata Therapeutics
LISATA THERAPEUTICS, INC.
Lisata Therapeutics is a pharma organization headquartered in basking ridge, USA. It trades on NYSE under ticker LSTA. Primary therapeutic focus areas include Covid-19, Chronic Myocardial Ischemia, Stage IV Melanoma, Kid
110 Allen Road, 2nd Flr, Basking Ridge, NJ 07920, US HQ
2006 Founded
38 Employees
Public company Type
LSTA · NYSE Ticker
Company details
- Status
- Public
- HQ
- 110 Allen Road, 2nd Flr, Basking Ridge, NJ 07920, US
- Founded
- 2006
- Employees
- 38
- Programs
- 15
- Drugs
- 13
- Patents
- 1
Auto-CD34+ cells
Phase 3 · mab · Chronic Myocardial Ischemia
Auto-CD34+ cells for Chronic Myocardial Ischemia is a Phase 3 program (mab) at LISATA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Internal code 901001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- LISATA THERAPEUTICS, INC.
- Phase
- Phase 3
- Modality
- mab
- Indication
- Chronic Myocardial Ischemia
- Status
- completed
- Trials
- 1